Travel Grants & Awards
39th Annual Scientific Meeting
The Langham Melbourne
26 – 28 July 2017
The Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) is the largest independent, oncology clinical trials research group in Australia and New Zealand. For almost 40 years, the ANZBCTG has conducted clinical trials for the treatment, prevention and cure of breast cancer.
The research program involves multicentre national and international clinical trials and brings together over 800 researchers in 87 institutions throughout Australia and New Zealand. The ANZBCTG has contributed to more than 1,000 peer reviewed publications and more than 14,000 women have participated in ANZBCTG clinical trials. The ANZBCTG’s fundraising department is the
Breast Cancer Institute of Australia
The 2017 Annual Scientific Meeting (ASM) will host a number of internationally renowned guest speakers including key ANZBCTG researchers. Delegates include leading Australian and New Zealand
medical practitioners and clinicians, and clinical trials management personnel.
The full and extensive program will include two days of scientific sessions covering timely reviews of breast cancer clinical trials, discussion of new protocols, future clinical trials research and other research developments.
A conference app containing the full program will be available in July.
The ASM is an opportunity for breast cancer researchers throughout Australia and New Zealand to learn of recent advances in breast cancer research worldwide; to share knowledge and research outcomes; and to collaborate, plan and strategise for new breast cancer clinical trials research initiatives.
The ANZBCTG ASM is not open to the general public to attend.
Find out more about the
ASM Program including
Dr Fatima Cardoso
Dr Cardoso is the Director of the Breast Unit of the Champalimaud Clinical Cancer in Lisbon, Portugal. Dr Cardoso’s research interests include biology of breast cancer, prognostic and predictive markers of response to systemic therapy, and new anticancer agents.
A/Prof Richard Finn
Associate Professor Finn is an Associate Professor of Medicine in the Division of Hematology/Oncology at the UCLA David Geffen School of Medicine and co-director of the Signal Transduction Program in the Jonsson Comprehensive Cancer Center at UCLA.
Prof Boon Chua
Professor Chua is the Director of Cancer and Haematology Services at the Prince of Wales Hospital and the University of New South Wales in Sydney.
Prof Sunil Lakhani
Professor Lakhani is the Head of Discipline of Molecular and Cellular Pathology at The University of Queensland’s School of Medicine, Head of the Breast Group at The University of Queensland Centre for Clinical Research (UQCCR) and Executive Director of Research at Pathology Queensland.
The 2017 ANZBCTG ASM will be held at
The Langham in Melbourne
More location information
Register your attendance at the 2017 ANZBCTG ASM
Past Annual Scientific Meetings